[Nitric oxide--a potential modulator of left ventricular diastolic function in hemodialysis patients treated with erythropoietin].
Left ventricular hypertrophy (LVH) is commonly present in hemodialysis patients (HD pts) and is considered as an independent risk factor for high mortality. Many studies have confirmed sound connection between anemia and LVH in this patients.


OBJECTIVE
To analyse dystolic function of LVH in uraemic pts during the 6 months human recombinant erythropoectin (rHu-Epo) treatment of anemia, with emphasis on the role of nitric oxide (NO), whose role in regulation of LV diastolic distensibility has been hinted in some recent studies.


METHODS
The study included 20 HD pts, aged 39.6 +/- 5.3 yrs, with the same condition of HD treatment, signs of anemia and echocardiographically verified LVH. Pulse Doppler echocardiography confirmed LV diastolic function as a ratio of early to late diastolic mitral flow velocity (E/A). Nitrate concentration was determined by colorimetric method using Greiss reagent. Renal anemia was treated with rHuEpo.


RESULTS
Six months rHuEpo treatment of anemia in HD pts with LVH caused significant reduction of LV mass index (p = 0.008). However, we observed unfavourable fall in LV diastolic function (E/A = 0.83, p = 0.007). In the same time, it was found that the serum NO level was higher for 11.8% in HD pts with LVH as compared with the pts with normal LV mass. Also, the significant positive correlation was found between the level of NO and LV mass index before (p = 0.004) and after rHuEpo therapy (p = 0.03), as well as a significant positive correlation between NO and E/A in the same conditions (p = 0.002) and p = 0.049). Level of NO negatively correlates with blood hemoglobin level, but without statistical significance.


CONCLUSIONS
Correction of anemia with rHuEpo leads to the significant partial regression of LVH. Reduction of diastolic function of LV, observed after diminished LV mass index, could be related to the significant fall of NO level and damaged response of LV to NO. The results of the study strongy suggest that NO can present an important determinant of LV diastolic function in uraemic pts.
Rasić
Senija
S
Institut za nefrologiju, Kardioloska klinika-Klinicki centar Univerziteta Sarajevo.
Kulenović
Indira
I
Zulić
Irfan
I
Huskić
Jasminko
J
Avdagić
N
N
Babić
N
N
Uncanin
Snjezana
S
Haracić
A
A
D000328:Adult; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D003971:Diastole; D018619:Echocardiography, Doppler, Pulsed; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000000981:diagnostic imaging / Q000209:etiology / Q000503:physiopathology*; D009569:Nitric Oxide / Q000097:blood / Q000502:physiology*; D011994:Recombinant Proteins; D006435:Renal Dialysis; D016277:Ventricular Function, Left / Q000502:physiology*
D011994:Recombinant Proteins; D004921:Erythropoietin; D009569:Nitric Oxide